Application no. and date | 00943666.8 (espacenet) (Federated) (European Patent Register), 20000526 | Patent/reg. no. and date | DK/EP 1185291, 20040204 | Publication date | 20020313 | Priority no. and date | DE 19925739, 19990607 | EP pub. no. and date |
EP 1185291 20020313 | Effective date | | Applicant/owner | Merz Pharma GmbH & Co. KGaA, Eckenheimer Landstrasse 100
60318 Frankfurt, DE | Applicant ref. no. | 108237 | Inventor | BIGALKE, Hans, Böttcherstrasse 4
D-30419 Hannover, DE, FREVERT, Jürgen, Hermannswerder Haus 17
D-14473 Potsdam, DE | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | Opponent | | IPC Class | A61K 38/16 (2006.01) , A61K 8/00 (2006.01) , A61P 25/00 (2006.01) , C07K 14/33 (2006.01) | Title | Terapeutisk middel til et botulinum-neurotoksin | Int. application no. | DE2000001777 | Int. publication no. | WO2000074703 | Related patent (certificate) | | Status | Ændret EP patent ikke valid i DK | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|